Add to Google
Date :
Time :
Advertising : Place your textual ad here - Latest News headlines : First Human Embryonic Stem Cell Lines Approved for Use Under New NIH Guidelines - PPD Launches New Global Biostatistics Technology Infrastructure - Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain -
  Print



Custom Tissue Sections & Microarrays

By AMS Biotechnology (AMSBIO)
Publication date : Thursday, 03 December 2009

Amsbio offers services for custom acquisition, procurement and preparation of tissue sections and

tissue microarrays from a wide range ofanimal and plant species according to client specification.

Drawing upon many years of experience amsbio is able to provide expert consultancy on the design and development of custom tissue sections and tissue microarrays.

Knowledgeable technical staff is available help you select the appropriate biospecimens from our comprehensive repository of tissue samples or provide effective solutions for scientifically challenging tissue acquisition projects.

High-quality certified tissues are available as frozen blocks and snap frozen samples, paraffin blocks, paraffin fixed or frozen tissue arrays, mounted sections and section panels as well as tumour/normal matched pair samples. A wide range of custom human biospecimens are available covering many human therapeutic areas including oncology, cardiovascular diseases, inflammatory diseases, neurology and diabetes/obesity.

Amsbio also provide blood specimens from patients with solid tumour and haematological malignancies in a variety of preparations.

Founded in 1987, AMS Biotechnology (amsbio) is recognised as a leading international provider of unique & innovative products & custom services for life sciences research.

The amsbio range includes over 23,000 polyclonal & monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & tissue DNA, RNA, protein & microarray products. Key research areas include: apoptosis, cell invasion & migration, cell signaling, DNA damage, electrophoresis, glycobiology, post-translational modification & stem cell biology.


Want to read more?

Actelion's miglustat in Niemann-Pick type C disease
Novartis receives approval in Switzerland for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine
Boehringer Ingelheim and GlaxoSmithKline back EFA`s call for urgent improvements in care for people with lung disease this World COPD Day

NEW SERVICE !
pharmaceutical press release publication

PRODUCT AWARD


PERSPECTIVES



OFFICIAL PARTNERS
ICSE Partner

PMEC Partner

Bio Manufacturing Summit Partner

American Conference Institute Partner

WTP partner

NEW! Send your Press Release for publication - Related Pharmaceutical websites : Asia Manufacturing Pharma | Pharmaceutical Manufacturing News
Pharmaceutical packaging | APIs | Excipients | Generics | Processing | Outsourcing | QA/QC | Pharma Strategy | Drug Discovery | Biotechnology | Clinical Dev.
Subscribe to Asia-Lifesiences.com | Unsubscribe from Asia-Lifesiences.com | Advertise | Privacy Statement | Copyright | Contact the publisher of this site

© Intelligent Publishing Media 2009 - All rights reserved.